EMEA-001903-PIP01-15

Key facts

Active substance
Efpeglenatide
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0181/2019
PIP number
EMEA-001903-PIP01-15
Pharmaceutical form(s)
Subcutaneous use
Condition(s) / indication(s)
Treatment of type II diabetes mellitus
Route(s) of administration
Solution for injection
Contact for public enquiries
Sanofi-Aventis Recherche & Développement

E-mail: contact-us@sanofi-aventis.com
Tel. +33 1 60 49 66 82

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating